Compare Stocks → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:AMTOTCMKTS:PYNKF Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMTAmerican Tower$171.30+0.2%$192.37$154.58▼$219.10$79.89B0.672.43 million shs2.87 million shsPYNKFPerimeter Medical Imaging AI$0.55-3.2%$0.67$0.54▼$1.50N/AN/A7,008 shs14,300 shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMTAmerican Tower-0.59%-4.28%-13.03%-16.12%-17.84%PYNKFPerimeter Medical Imaging AI-3.20%-8.44%-21.99%-31.15%-55.10%The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide!MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMTAmerican Tower4.9278 of 5 stars4.43.02.53.12.82.51.9PYNKFPerimeter Medical Imaging AIN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMTAmerican Tower2.82Moderate Buy$217.3626.89% UpsidePYNKFPerimeter Medical Imaging AIN/AN/AN/AN/ACurrent Analyst RatingsLatest PYNKF, 4DX, ADR, and AMT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/15/2024AMTAmerican TowerMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$183.00 ➝ $196.004/8/2024AMTAmerican TowerMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$205.003/5/2024AMTAmerican TowerBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$224.00 ➝ $234.002/28/2024AMTAmerican TowerBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$235.00 ➝ $228.002/28/2024AMTAmerican TowerJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$236.00 ➝ $230.001/24/2024AMTAmerican TowerBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$229.00 ➝ $224.00(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMTAmerican Tower$11.14B7.17$9.87 per share17.36$23.30 per share7.35PYNKFPerimeter Medical Imaging AIN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMTAmerican Tower$1.48B$3.1853.8716.601.3613.31%12.80%2.24%4/30/2024 (Confirmed)PYNKFPerimeter Medical Imaging AIN/AN/A0.00∞N/AN/AN/AN/A5/23/2024 (Estimated)Latest PYNKF, 4DX, ADR, and AMT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2024N/AAMTAmerican Tower$2.45N/A-$2.45N/AN/AN/A 2/27/202412/31/2023AMTAmerican Tower$2.10$0.94-$1.16$0.18$2.74 billion$2.79 billion DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMTAmerican Tower$6.483.78%+12.50%203.77%N/APYNKFPerimeter Medical Imaging AIN/AN/AN/AN/AN/ALatest PYNKF, 4DX, ADR, and AMT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/14/2024AMTAmerican Towerquarterly$1.623.3%4/11/20244/12/20244/26/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMTAmerican Tower3.290.690.69PYNKFPerimeter Medical Imaging AIN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMTAmerican Tower92.69%PYNKFPerimeter Medical Imaging AIN/AInsider OwnershipCompanyInsider OwnershipAMTAmerican Tower0.24%PYNKFPerimeter Medical Imaging AIN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAMTAmerican Tower5,643466.35 million465.23 millionOptionablePYNKFPerimeter Medical Imaging AI43N/AN/ANot OptionablePYNKF, 4DX, ADR, and AMT HeadlinesSourceHeadlinePerimeter Medical Imaging AI Announces Webinar Featuring AI Expert, Anantha Kancherla, Discussing Trends in the Use of Machine Learning and Artificial Intelligence in Healthcare Applicationsprnewswire.com - April 16 at 8:30 AMNon-invasive imaging test identifies patients needing heart proceduresmsn.com - April 14 at 7:33 AMA 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveriesmedindia.net - April 11 at 2:49 PMPerimeter Medical Imaging AI Announces Participation at the Upcoming Annual Meeting of the American Society of Breast Surgeons (ASBrS) and Provides Corporate Updatesprnewswire.com - April 4 at 5:17 PMPerimeter Medical Imaging AI, Inc. (PYNKF) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 30 at 11:15 PMHMS Study Casts Doubt on AI’s Diagnostic Accuracy in Radiologythecrimson.com - March 30 at 2:40 AMPerimeter Medical Imaging AI Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Updateprnewswire.com - March 28 at 4:01 PMPerimeter Medical Imaging AI Provides Corporate Update on Grant Funding Opportunities and Announces Conference Call/Webcast to Discuss Fourth Quarter and Year-End 2023 Financial Resultsfinance.yahoo.com - March 20 at 6:46 PMPerimeter Medical Imaging AI pushes forward despite federal grant challengesproactiveinvestors.com - March 20 at 4:33 PMPerimeter Medical Imaging AI technology plus OCT accurately identifies 96.8% of breast cancer margins: studyproactiveinvestors.com - February 29 at 10:06 AMPerimeter Medical Imaging AI Reports Its Proprietary Artificial Intelligence Algorithm + OCT Identified 96.8% of Positive Breast Cancer Margins in Newly Published Peer Reviewed Studyprnewswire.com - February 29 at 8:30 AMX-ray Imaging: Development of Interior Tomography for CT Scan 2/27uml.edu - February 24 at 2:57 AMForget Nvidia: AI stocks with significant growth potential to watchproactiveinvestors.com - February 20 at 4:16 PMPerimeter Medical Imaging AI addresses breast cancer reoperation ratesproactiveinvestors.com - February 20 at 10:01 AMPerimeter Medical Imaging AI Announces Publication of Peer-Reviewed Research Examining the High Rates of Re-Operations Following Breast-Conserving Surgeries and the Associated Increased Healthcare Costsfinance.yahoo.com - February 20 at 9:17 AMPerimeter Medical Imaging AI Announces Publication of Peer-Reviewed Research Examining the High Rates of Re-Operations Following Breast-Conserving Surgeries and the Associated Increased Healthcare Costsprnewswire.com - February 20 at 8:30 AMPerimeter Medical Imaging AI Announces Expanded Commercial Presence within National Healthcare Provider System with Follow-On Placement of Perimeter S-Series OCT at Additional Hospital Sitefinance.yahoo.com - February 7 at 12:46 PMPerimeter Medical Imaging AI Announces Further Commercial Expansion in North Texas with Follow-On Placement of Perimeter S-Series OCT within National Healthcare Provider Systemfinance.yahoo.com - December 14 at 12:56 PMPerimeter Medical Imaging AI Announces Investor Webinar Featuring Breast Surgeon KOL to Discuss Re-excision Epidemic and Potential Benefits of AI in Cancer Surgeryfinance.yahoo.com - November 27 at 9:32 AMPerimeter Medical Imaging, Inc.: Perimeter Medical Imaging AI Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - November 15 at 7:11 PMPerimeter Medical Imaging AI reports Q3 resultsmsn.com - November 14 at 6:04 PMPerimeter Medical Imaging AI Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 14 at 6:04 PMPerimeter Medical Imaging AI sets 3Q earnings date; CEO conference callproactiveinvestors.com - November 9 at 12:06 PMPerimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Updatefinance.yahoo.com - November 8 at 4:05 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAmerican TowerNYSE:AMTAmerican Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.Perimeter Medical Imaging AIOTCMKTS:PYNKFPerimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT and B-series OCT. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. The company was founded in 2013 and is headquartered in Toronto, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.